PathogenDx
Scottsdale, US · Founded 2015 · Delaware corporation · 3 known investors
PathogenDx provides molecular pathogen detection assays using proprietary D3 Technology for rapid, multiplexed identification of bacterial, fungal, and viral pathogens in food, agricultural, clinical, and environmental samples.
Founders & leadership
PathogenDx was founded in 2015 by Michael Hogan and Milan Patel.
MH
Michael HoganCSO
MP

Milan PatelCEO
EL
Eric LachanceCOO
Investors · 3
Competitors · 4
by search overlapGendx20 shared keywordsGenDx is a molecular diagnostics company specializing in HLA typing and other reagents and software for pre- and post-transplant testing in diagnostic laboratories. It serves the transplantation and personalized healthcare field, offering NGS-based HLA typing products, software, and educational support.
Genedx15 shared keywordsGeneDx provides genetic testing for rare and inherited conditions, including exome, genome, trio, and prenatal sequencing, paired with clinical interpretation and a large rare disease dataset. It serves clinicians, patients, and biopharma partners to support earlier diagnoses and precision medicine.
CareDx14 shared keywordsCareDx provides molecular diagnostic testing, workflow software, patient support, and pharmacy services for care teams working in transplant, cell therapy, and specialty oncology. Its products support rejection monitoring and complex care management in precision medicine.
Medicinalgenomics14 shared keywordsMedicinal Genomics develops qPCR-based testing technologies used to verify product safety and regulatory compliance. Its tools serve testing labs, manufacturers, and brands.
Companies competing with PathogenDx for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements$675K disclosed across 1 round · 2016
▶$675KraisedApr 2016 · 4 investors · Biotechnology
▶$675KraisedApr 2016 · 4 investors · Biotechnology
Officers, directors & promoters on the filing
- Eric LachanceExecutive Officer, Director
- Michael HoganExecutive Officer, Director
- Milan PatelExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $675K
- Minimum investment
- $50K
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 05
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.